Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease

Identifieur interne : 000228 ( France/Analysis ); précédent : 000227; suivant : 000229

Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease

Auteurs : Marie-Paule Muriel [France] ; Véronique Bernard [France] ; Allan I. Levey [États-Unis] ; Ouahiba Laribi [France] ; D. Nora Abrous [France] ; Yves Agid [France] ; Bertrand Bloch [France] ; Etienne C. Hirsch [France]

Source :

RBID : ISTEX:7B6BBD326887F65BDFAE6C9B90817F45C5C0455A

Abstract

Parkinson's disease is characterized by a massive loss of nigral dopamine neurons that results in a reduction of dopamine concentrations in the striatum. The most commonly used treatment for this disease is levodopa therapy to restore striatal dopamine. This treatment is mediated by dopamine receptors, but the effect of treatment and the disease on receptor distribution is unknown. In this study, the distribution of D1 dopamine receptors was analyzed at the cellular and subcellular level in the striatum of 5 patients with Parkinson's disease (all treated with levodopa) and 4 control subjects. In the control brains, D1 dopamine receptors were mostly detected on the plasma membrane of medium‐sized spiny neurons. The quantitative analysis performed at the ultrastructural level in patients with Parkinson's disease revealed an increase in immunostaining in the cytoplasm of medium‐sized neurons. This effect was likely the result of the treatment rather than the dopaminergic denervation, as such changes were not observed in the striatum of rats with a unilateral 6‐hydroxydopamine nigrostriatal lesion, but were present in normal or lesioned rats treated with a D1 dopamine agonist. Altered localization of D1 dopamine receptors may participate in the occurrence of side effects of levodopa therapy such as dyskinesia and fluctuations in motor performances. Ann Neurol 1999;46:103–111

Url:
DOI: 10.1002/1531-8249(199907)46:1<103::AID-ANA15>3.0.CO;2-Z


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:7B6BBD326887F65BDFAE6C9B90817F45C5C0455A

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease</title>
<author>
<name sortKey="Muriel, Marie Aule" sort="Muriel, Marie Aule" uniqKey="Muriel M" first="Marie-Paule" last="Muriel">Marie-Paule Muriel</name>
</author>
<author>
<name sortKey="Bernard, Veronique" sort="Bernard, Veronique" uniqKey="Bernard V" first="Véronique" last="Bernard">Véronique Bernard</name>
</author>
<author>
<name sortKey="Levey, Allan I" sort="Levey, Allan I" uniqKey="Levey A" first="Allan I." last="Levey">Allan I. Levey</name>
</author>
<author>
<name sortKey="Laribi, Ouahiba" sort="Laribi, Ouahiba" uniqKey="Laribi O" first="Ouahiba" last="Laribi">Ouahiba Laribi</name>
</author>
<author>
<name sortKey="Abrous, D Nora" sort="Abrous, D Nora" uniqKey="Abrous D" first="D. Nora" last="Abrous">D. Nora Abrous</name>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation>
<country>France</country>
<placeName>
<settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
<author>
<name sortKey="Bloch, Bertrand" sort="Bloch, Bertrand" uniqKey="Bloch B" first="Bertrand" last="Bloch">Bertrand Bloch</name>
</author>
<author>
<name sortKey="Hirsch, Etienne C" sort="Hirsch, Etienne C" uniqKey="Hirsch E" first="Etienne C." last="Hirsch">Etienne C. Hirsch</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7B6BBD326887F65BDFAE6C9B90817F45C5C0455A</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1002/1531-8249(199907)46:1<103::AID-ANA15>3.0.CO;2-Z</idno>
<idno type="url">https://api.istex.fr/document/7B6BBD326887F65BDFAE6C9B90817F45C5C0455A/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001396</idno>
<idno type="wicri:Area/Main/Curation">001183</idno>
<idno type="wicri:Area/Main/Exploration">001D71</idno>
<idno type="wicri:Area/France/Extraction">000228</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease</title>
<author>
<name sortKey="Muriel, Marie Aule" sort="Muriel, Marie Aule" uniqKey="Muriel M" first="Marie-Paule" last="Muriel">Marie-Paule Muriel</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U289, Hôpital de la Salpêtrière, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bernard, Veronique" sort="Bernard, Veronique" uniqKey="Bernard V" first="Véronique" last="Bernard">Véronique Bernard</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5541, Laboratoire d'Histologie Embryologie, Université Victor Ségalen‐Bordeaux 2, Bordeaux</wicri:regionArea>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Levey, Allan I" sort="Levey, Allan I" uniqKey="Levey A" first="Allan I." last="Levey">Allan I. Levey</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Department of Neurology, Emory University School of Medicine, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Laribi, Ouahiba" sort="Laribi, Ouahiba" uniqKey="Laribi O" first="Ouahiba" last="Laribi">Ouahiba Laribi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5541, Laboratoire d'Histologie Embryologie, Université Victor Ségalen‐Bordeaux 2, Bordeaux</wicri:regionArea>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Abrous, D Nora" sort="Abrous, D Nora" uniqKey="Abrous D" first="D. Nora" last="Abrous">D. Nora Abrous</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U279 Institut Fédératif de Recherche en Neurosciences Cliniques et Expérimentales, Université Victor Ségalen‐Bordeaux 2, Bordeaux</wicri:regionArea>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U289, Hôpital de la Salpêtrière, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
<placeName>
<settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
<author>
<name sortKey="Bloch, Bertrand" sort="Bloch, Bertrand" uniqKey="Bloch B" first="Bertrand" last="Bloch">Bertrand Bloch</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité Mixte de Recherche Centre National de la Recherche Scientifique 5541, Laboratoire d'Histologie Embryologie, Université Victor Ségalen‐Bordeaux 2, Bordeaux</wicri:regionArea>
<placeName>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, Etienne C" sort="Hirsch, Etienne C" uniqKey="Hirsch E" first="Etienne C." last="Hirsch">Etienne C. Hirsch</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U289, Hôpital de la Salpêtrière, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of Neurology</title>
<title level="j" type="abbrev">Ann Neurol.</title>
<idno type="ISSN">0364-5134</idno>
<idno type="eISSN">1531-8249</idno>
<imprint>
<publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="1999-07">1999-07</date>
<biblScope unit="volume">46</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="103">103</biblScope>
<biblScope unit="page" to="111">111</biblScope>
</imprint>
<idno type="ISSN">0364-5134</idno>
</series>
<idno type="istex">7B6BBD326887F65BDFAE6C9B90817F45C5C0455A</idno>
<idno type="DOI">10.1002/1531-8249(199907)46:1<103::AID-ANA15>3.0.CO;2-Z</idno>
<idno type="ArticleID">ANA15</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0364-5134</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease is characterized by a massive loss of nigral dopamine neurons that results in a reduction of dopamine concentrations in the striatum. The most commonly used treatment for this disease is levodopa therapy to restore striatal dopamine. This treatment is mediated by dopamine receptors, but the effect of treatment and the disease on receptor distribution is unknown. In this study, the distribution of D1 dopamine receptors was analyzed at the cellular and subcellular level in the striatum of 5 patients with Parkinson's disease (all treated with levodopa) and 4 control subjects. In the control brains, D1 dopamine receptors were mostly detected on the plasma membrane of medium‐sized spiny neurons. The quantitative analysis performed at the ultrastructural level in patients with Parkinson's disease revealed an increase in immunostaining in the cytoplasm of medium‐sized neurons. This effect was likely the result of the treatment rather than the dopaminergic denervation, as such changes were not observed in the striatum of rats with a unilateral 6‐hydroxydopamine nigrostriatal lesion, but were present in normal or lesioned rats treated with a D1 dopamine agonist. Altered localization of D1 dopamine receptors may participate in the occurrence of side effects of levodopa therapy such as dyskinesia and fluctuations in motor performances. Ann Neurol 1999;46:103–111</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Géorgie (États-Unis)</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Bordeaux</li>
<li>Paris</li>
</settlement>
<orgName>
<li>Hôpital de la Salpêtrière</li>
</orgName>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Muriel, Marie Aule" sort="Muriel, Marie Aule" uniqKey="Muriel M" first="Marie-Paule" last="Muriel">Marie-Paule Muriel</name>
</noRegion>
<name sortKey="Abrous, D Nora" sort="Abrous, D Nora" uniqKey="Abrous D" first="D. Nora" last="Abrous">D. Nora Abrous</name>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<name sortKey="Bernard, Veronique" sort="Bernard, Veronique" uniqKey="Bernard V" first="Véronique" last="Bernard">Véronique Bernard</name>
<name sortKey="Bloch, Bertrand" sort="Bloch, Bertrand" uniqKey="Bloch B" first="Bertrand" last="Bloch">Bertrand Bloch</name>
<name sortKey="Hirsch, Etienne C" sort="Hirsch, Etienne C" uniqKey="Hirsch E" first="Etienne C." last="Hirsch">Etienne C. Hirsch</name>
<name sortKey="Laribi, Ouahiba" sort="Laribi, Ouahiba" uniqKey="Laribi O" first="Ouahiba" last="Laribi">Ouahiba Laribi</name>
</country>
<country name="États-Unis">
<region name="Géorgie (États-Unis)">
<name sortKey="Levey, Allan I" sort="Levey, Allan I" uniqKey="Levey A" first="Allan I." last="Levey">Allan I. Levey</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000228 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000228 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:7B6BBD326887F65BDFAE6C9B90817F45C5C0455A
   |texte=   Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024